The impact of male factors and their correct and early diagnosis in the infertile couple's pathway: 2021 perspectives
- PMID: 35349114
- PMCID: PMC8961097
- DOI: 10.1007/s40618-022-01778-7
The impact of male factors and their correct and early diagnosis in the infertile couple's pathway: 2021 perspectives
Abstract
Purpose: The current clinical practice in reproductive medicine should pose the couple at the centre of the diagnostic-therapeutic management of infertility and requires intense collaboration between the andrologist, the gynaecologist and the embryologist. The andrologist, in particular, to adequately support the infertile couple, must undertake important biological, psychological, economical and ethical task. Thus, this paper aims to provide a comprehensive overview of the multifaceted role of the andrologist in the study of male factor infertility.
Methods: A comprehensive Medline, Embase and Cochrane search was performed including publications between 1969 and 2021.
Results: Available evidence indicates that a careful medical history and physical examination, followed by semen analysis, always represent the basic starting points of the diagnostic work up in male partner of an infertile couple. Regarding treatment, gonadotropins are an effective treatment in case of hypogonadotropic hypogonadism and FSH may be used in men with idiopathic infertility, while evidence supporting other hormonal and nonhormonal treatments is either limited or conflicting. In the future, pharmacogenomics of FSHR and FSHB as well as innovative compounds may be considered to develop new therapeutic strategies in the management of infertility.
Conclusion: To provide a high-level of care, the andrologist must face several critical diagnostical and therapeutical steps. Even though ART may be the final and decisive stage of this decisional network, neglecting to treat the male partner may ultimately increase the risks of negative outcome, as well as costs and psychological burden for the couple itself.
Keywords: ART; Couple infertility; FSH; Male factor; Semen analysis.
© 2022. The Author(s).
Conflict of interest statement
AB, GC, GR and DS are members of the editorial board. The remaining Authors have no potential conflicts of interest to disclose.
Figures
Similar articles
-
FSHB -211G>T stratification for follicle-stimulating hormone treatment of male infertility patients: making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism.Andrology. 2015 Nov;3(6):1050-3. doi: 10.1111/andr.12094. Epub 2015 Oct 7. Andrology. 2015. PMID: 26445243
-
APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function.Reprod Biomed Online. 2024 Apr;48(4):103647. doi: 10.1016/j.rbmo.2023.103647. Epub 2023 Oct 29. Reprod Biomed Online. 2024. PMID: 38367592
-
FSH for the Treatment of Male Infertility.Int J Mol Sci. 2020 Mar 25;21(7):2270. doi: 10.3390/ijms21072270. Int J Mol Sci. 2020. PMID: 32218314 Free PMC article. Review.
-
Prospects for FSH Treatment of Male Infertility.J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa243. doi: 10.1210/clinem/dgaa243. J Clin Endocrinol Metab. 2020. PMID: 32374828
-
Extensive Assessment of Underlying Etiological Factors in Primary Infertile Men Reduces the Proportion of Men With Idiopathic Infertility.Front Endocrinol (Lausanne). 2021 Dec 24;12:801125. doi: 10.3389/fendo.2021.801125. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002977 Free PMC article.
Cited by
-
Bladder Neck Obstruction: Experience and Management in a Sperm Bank.Life (Basel). 2023 Mar 20;13(3):842. doi: 10.3390/life13030842. Life (Basel). 2023. PMID: 36983997 Free PMC article.
-
Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes.J Endocrinol Invest. 2023 Jun;46(6):1079-1085. doi: 10.1007/s40618-022-02000-4. Epub 2023 Jan 12. J Endocrinol Invest. 2023. PMID: 36633791 Free PMC article. Review.
-
Comment on Boitrelle et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis. Life 2021, 11, 1368.Life (Basel). 2022 Jul 13;12(7):1044. doi: 10.3390/life12071044. Life (Basel). 2022. PMID: 35888132 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical